Prevalensi Manifestasi Neurologis Pada Pasien COVID-19 di RSPAL Surabaya Periode April
Article Sidebar
Main Article Content
Abstract
Latar belakang : COVID-19 adalah penyakit pneumonia atipikal yang disebabkan
SARS-CoV-2. Penyebaran dan tingkat kematian yang meningkat setiap harinya serta
manifestasi klinis yang beragam salah satunya manifestasi neurologis. Manifestasi
neurologis dari COVID-19 dapat memengaruhi baik CNS ataupun PNS dengan
diagnosis seperti meningoencephalitis, kejadian cerebrovaskuler, kejang, GBS, dan
anosmia/ageusia (Desai,I., et al, 2021).
Tujuan penelitian : Untuk meneliti manifestasi neurologis pada pasien covid-19 di
RSPAL Surabaya periode April 2020 – April 2021.
Metode penelitian : Penelitian ini adalah penelitian deskriptif. Sampel berupa
manifestasi neurologis seperti stroke iskemik dan hemoragik, epilepsi, GBS,
meningoencephalitis, dan anosmia/ageusia pada pasien dengan RT-PCR COVID-19
yang postif. Sampel yang dicari merupakan data sekunder dari rekam medik RSPAL
Surabaya mulai dari periode April 2020 – April 2021.
Hasil penelitian : Dari total 3346 kasus COVID-19 didapatkan 77 kasus COVID-19
dengan 84 manifestasi neurologis berbeda. Terdapat 36 (1,08%) kasus
anosmia/ageusia, kasus stroke iskemik dengan total 26 (0,78%) kasus, terdapat 13
(0,39%) kasus epilepsi, stroke hemoragik dengan 5 (0,15%) kasus,
meningoencephalitis dengan 2 (0,06%) kasus, GBS sebanyak 2 (0,06%) kasus.
Tercatat puncak kasus COVID-19 dengan manifestasi neurologis pada bulan Januari
2021 dan serendah-rendahnya pada bulan April 2020 dan Mei 2020.
Kesimpulan : Terdapat 84 kasus manifestasi neurologis berupa stroke iskemik,
stroke hemoragik, anosmia/ageusia, epilepsi, GBS, meningoencephalitis pada 77
pasien COVID-19 di RSPAL Surabaya periode April 2020 – April 2021.
Kata kunci : Manifestasi neurologis, stroke iskemik, stroke hemoragik,
anosmia/ageusia, epilepsi, GBS, meningoencephalitis.
Article Details
References
Agyeman AA, Chin KL, Landersdorfer CB, Liew D, Ofori-Asenso R. Smell and Taste Dysfunction in Patients With COVID-19: A Systematic Review and Meta-analysis. Mayo Clin Proc. 2020 Aug;95(8):1621-1631. doi: 10.1016/j.mayocp.2020.05.030. Epub 2020 Jun 6. PMID: 32753137; PMCID: PMC7275152.
Bhatt T, Kumar V, Pande S, Malik R, Khamparia A, Gupta D. A Review on COVID-19. Stud Comput Intell. 2021;924(April):25-42. doi:10.1007/978-3-030-60188-1_2
Cascella M, Rajnik M, Aleem A, et al. Features, Evaluation, and Treatment of Coronavirus (COVID-19) [Updated 2021 Jul 17]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK554776/
Cevik M, Kuppalli K, Kindrachuk J, Peiris M. Virology, transmission, and pathogenesis of SARS-CoV-2. BMJ. 2020;371:1-6. doi:10.1136/bmj.m3862
COVID-19, W. R. P. (n.d.). Peta Sebaran. covid19.go.id. Retrieved January 2, 2022, from https://covid19.go.id/peta-sebaran
Desai I, Manchanda R, Kumar N, Tiwari A, Kumar M. Neurological manifestations of coronavirus disease 2019: exploring past to understand present. Neurol Sci. 2021;42(3):773-785. doi:10.1007/s10072-020-04964-8
Dhamoon MS, Thaler A, Gururangan K, et al. Acute Cerebrovascular Events with COVID-19 Infection. Stroke. 2021;(January):48-56. doi:10.1161/STROKEAHA.120.031668
Diaz, Janet; Appiah, John; Askie, Lisa; Baller, April; Banerjee, Anshu; Barkley, Shannon; Bertagnolio, Silvia; Hemmingsen, Bianca; Bonet, Mercedes; Cunningham J. Clinical management Clinical management Living guidance COVID-19. World Heal Organ. 2021;(January).
Duan G. Intuition on virology, epidemiology, pathogenesis, and control of COVID-19. Nov Res Microbiol J. 2020;4(5):955-967. doi:10.21608/nrmj.2020.118446
Frye BC, Meiss F, von Bubnoff D, Zissel G, Müller-Quernheim J. Vasoactive Intestinal Peptide in Checkpoint Inhibitor–Induced Pneumonitis. N Engl J Med. 2020;382(26):2573-2574. doi:10.1056/nejmc2000343
Hall JE, Hall ME. Guyton and Hall: Textbook of Medical Physiology 14th Edition. Elsevier. Published online 2021:973-989.
Harrison C, Fortin M, van den Akker M, et al. Comorbidity versus multimorbidity: Why it matters. J Comorb. 2021;11:2633556521993993. Published 2021 Mar 2. doi:10.1177/2633556521993993
Hui C, Tadi P, Patti L. Ischemic Stroke. [Updated 2021 Sep 29]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK499997/?report=classic
Khan, F., Sharma, P., Pandey, S., Sharma, D., Vijayavarman, V., Kumar, N., Shukla, S., Dandu, H., Jain, A., Garg, R. K., & Malhotra, H. S. (2021). COVID-19-associated Guillain-Barre syndrome: Postinfectious alone or neuroinvasive too? Journal of Medical Virology, 93(10), 6045–6049. https://doi.org/10.1002/jmv.27159
Kuroda, N. (2021). Epilepsy and COVID-19: Updated evidence and narrative review. In Epilepsy and Behavior (Vol. 116). Academic Press Inc. https://doi.org/10.1016/j.yebeh.2021.107785
Kutsuna S. Clinical Manifestations of Coronavirus Disease 2019. JMA J. 2021;4(2):76-80. doi:10.31662/jmaj.2021-0013
La Marca A, Capuzzo M, Paglia T, Roli L, Trenti T, Nelson SM. Testing for SARS-CoV-2 (COVID-19): a systematic review and clinical guide to molecular and serological in-vitro diagnostic assays. Reprod Biomed Online. 2020;41(3):483-499. doi:10.1016/j.rbmo.2020.06.001
las Casas Lima, M. H. de, Cavalcante, A. L. B., & Leão, S. C. (2021). Pathophysiological relationship between COVID-19 and olfactory dysfunction: A systematic review. In Brazilian Journal of Otorhinolaryngology. Elsevier Editora Ltda. https://doi.org/10.1016/j.bjorl.2021.04.001
Leasure, A. C., Khan, Y. M., Iyer, R., Elkind, M. S. V., Sansing, L. H., Falcone, G. J., & Sheth, K. N. (2021). Intracerebral Hemorrhage in Patients With COVID-19: An Analysis From the COVID-19 Cardiovascular Disease Registry. In Stroke (Vol. 52, Issue 7, pp. e321–e323). NLM (Medline). https://doi.org/10.1161/STROKEAHA.121.034215
Li X, Lui F. Anosmia. [Updated 2021 Mar 24]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK482152/
Luo W, Liu X, Bao K, Huang C. Ischemic stroke associated with COVID-19: a systematic review and meta-analysis. J Neurol. 2021;(0123456789):1-10. doi:10.1007/s00415-021-10837-7
Mao L, Jin H, Wang M, et al. Neurologic Manifestations of Hospitalized Patients with Coronavirus Disease 2019 in Wuhan, China. JAMA Neurol. 2020;77(6):683-690. doi:10.1001/jamaneurol.2020.1127
Melguizo I, Gilbert M, Tummala S. Guillain-Barré syndrome and glioblastoma. J Neurooncol. 2011;104(1):371-373. doi:10.1007/s11060-010-0471-7
Mescher A. Junqueras’s Basic Histology Text and Atlas.; 2016.
Mondal R, Ganguly U, Deb S, et al. Meningoencephalitis associated with COVID-19: a systematic review. J Neurovirol. 2021;27(1):12-25. doi:10.1007/s13365-020-00923-3
Moore, Keith L., A. M. R. Agur, and Arthur F. Dalley. Essential Clinical Anatomy. Baltimore, MD: Lippincott Williams & Wilkins, 2019.
Nguyen TP, Taylor RS. Guillain Barre Syndrome. [Updated 2020 Nov 19]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK532254/
Ouassou H, Kharchoufa L, Bouhrim M, et al. The Pathogenesis of Coronavirus Disease 2019 (COVID-19): Evaluation and Prevention. J Immunol Res. 2020;2020. doi:10.1155/2020/1357983
Parasher A. COVID-19: Current understanding of its Pathophysiology, Clinical presentation and Treatment. Postgrad Med J. 2021;97(1147):312-320. doi:10.1136/postgradmedj-2020-138577
Qureshi AI, Baskett WI, Huang W, et al. Acute Ischemic Stroke and COVID-19: An Analysis of 27 676 Patients. Stroke. 2021;(March):905-912. doi:10.1161/STROKEAHA.120.031786
Qureshi, A. I., Baskett, W. I., Huang, W., Shyu, D., Myers, D., Lobanova, I., Ishfaq, M. F., Naqvi, S. H., French, B. R., Siddiq, F., Gomez, C. R., & Shyu, C. R. (2021). Subarachnoid Hemorrhage and COVID-19: An Analysis of 282,718 Patients. World Neurosurgery, 151, e615–e620. https://doi.org/10.1016/j.wneu.2021.04.089
Rajdev, K., Lahan, S., Klein, K., Piquette, C. A., & Thi, M. (2020). Acute Ischemic and Hemorrhagic Stroke in COVID-19: Mounting Evidence. Cureus. https://doi.org/10.7759/cureus.10157
Rathee M, Jain P. Ageusia. [Updated 2021 Feb 13]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK549775/
Sacco RL, Kasner SE, Broderick JP, et al. An updated definition of stroke for the 21st century: A statement for healthcare professionals from the American heart association/American stroke association. Stroke. 2013;44(7):2064-2089. doi:10.1161/STR.0b013e318296aeca
Simon RP, Aminoff MJ, Greenberg DA. Clinical Neurology Tenth Edition. Vol 18.; 2018.
Srinivasan, M. (2021). Taste Dysfunction and Long COVID-19. Frontiers in Cellular and Infection Microbiology, 11. https://doi.org/10.3389/fcimb.2021.716563
Tang Y, Schmitz JE, Persing DH, Stratton CW. crossm Challenges. J Clin Microbiol. 2020;58(6):1-9.
Toscano G, Palmerini F, Ravaglia S, et al. Guillain–Barré Syndrome Associated with SARS-CoV-2. N Engl J Med. 2020;382(26):2574-2576. doi:10.1056/NEJMc2009191
Tsai PH, Lai WY, Lin YY, et al. Clinical manifestation and disease progression in COVID-19 infection. J Chinese Med Assoc. 2021;84(1):3-8. doi:10.1097/JCMA.0000000000000463
Weinstein S. Seizures and epilepsy: An overview. Epilepsy Intersect Neurosci Biol Math Eng Phys. Published online 2016:65-77. doi:10.1201/b10866-10
Whittaker, A., Anson, M., & Harky, A. (2020). Neurological Manifestations of COVID-19: A systematic review and current update. In Acta Neurologica Scandinavica (Vol. 142, Issue 1, pp. 14–22). Blackwell Publishing Ltd. https://doi.org/10.1111/ane.13266
Wiersinga WJ, Rhodes A, Cheng AC, Peacock SJ, Prescott HC. Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review. JAMA - J Am Med Assoc. 2020;324(8):782-793. doi:10.1001/jama.2020.12839
Yaghi S, Ishida K, Torres J, et al. SARS-CoV-2 and Stroke in a New York Healthcare System [published correction appears in Stroke. 2020 Aug;51(8):e179]. Stroke. 2020;51(7):2002-2011. doi:10.1161/STROKEAHA.120.030335
Zhang, L., Zhou, L., Bao, L., Liu, J., Zhu, H., Lv, Q., Liu, R., Chen, W., Tong, W., Wei, Q., Xu, Y., Deng, W., Gao, H., Xue, J., Song, Z., Yu, P., Han, Y., Zhang, Y., Sun, X., … Qin, C. (2021). SARS-CoV-2 crosses the blood–brain barrier accompanied with basement membrane disruption without tight junctions alteration. Signal Transduction and Targeted Therapy, 6(1). https://doi.org/10.1038/s41392-021-00719-9
Zheng J. SARS-coV-2: An emerging coronavirus that causes a global threat. Int J Biol Sci. 2020;16(10):1678-1685. doi:10.7150/ijbs.45053
Zheng Z, Peng F, Xu B, et al. Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysis. J Infect. 2020;81(2):e16-e25. doi:10.1016/j.jinf.2020.04.021